PXSV:NYE-Invesco S&P SmallCap Value with Momentum ETF (USD)

ETF | Small Value |

Last Closing

USD 54.21

Change

-0.78 (-1.42)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Small Value

Symbol Name Price(Change) Market Cap
VBR Vanguard Small-Cap Value Index..

-1.80 (-0.90%)

USD 31.09B
IJS iShares S&P Small-Cap 600 Valu..

-1.74 (-1.62%)

USD 7.20B
DES WisdomTree U.S. SmallCap Divid..

-0.48 (-1.39%)

USD 2.04B
XSVM Invesco S&P SmallCap Value wit..

-0.78 (-1.42%)

USD 0.82B
XSLV Invesco S&P SmallCap Low Volat..

-0.42 (-0.87%)

USD 0.33B
JKL iShares Morningstar Small-Cap ..

N/A

N/A
SLYV SPDR® S&P 600 Small Cap Value..

-1.34 (-1.54%)

N/A
RFV Invesco S&P MidCap 400® Pure ..

-1.38 (-1.17%)

N/A
VIOV Vanguard S&P Small-Cap 600 Val..

-1.27 (-1.37%)

N/A
FDM First Trust Dow Jones Select M..

-0.86 (-1.34%)

N/A

ETFs Containing PXSV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Small Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 87.25% 100% F 96% N/A
Dividend Return -14.26% 8% B- N/A F
Total Return 73.00% 100% F 94% A
Trailing 5 Years  
Capital Gain 87.25% 85% B 82% B
Dividend Return -14.26% 8% B- N/A F
Total Return 73.00% 69% C- 74% C
Average Annual (5 Year Horizon)  
Capital Gain 9.36% N/A N/A 66% D+
Dividend Return 8.38% N/A N/A 57% F
Total Return -0.98% N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 24.43% N/A N/A 42% F
Risk Adjusted Return 34.29% N/A N/A 51% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike